NEWS

LATEST TROPIQ NEWS

TropIQ enters partnership to combat vector-borne diseases

TropIQ joins forces with Protinhi Therapeutics, Radboud University and the Radboud University Medical Center in a project aimed at the discovery of novel therapeutics for malaria, dengue and Zika fever ...
Read more
/ News

TropIQ co-authors nature communications publication.

TropIQ co-authors the publication "A potent series targeting the malarial cGMP-dependent protein ...
Read more
/ News

TropIQ team contributes to study on Plasmodium kinase inhibitor

The publication "Antimalarial efficacy of MMV390048, an inhibitor of Plasmodium phosphatidylinositol 4-kinase." came out today ...
Read more
/ News

TropIQ receives price for Dutch innovative startup

TropIQ receives the Unilever Sustainable Innovation Prize for the Dutch innovative startup best contributing to the Sustainable Development Goals as put forward by the United Nations ...
Read more
/ News

TropIQ is awarded with a ‘Pearl of the region’

TropIQ is awarded with a 'Pearl of the region' award by The Economic Board. Waarom roept The Economic Board ‘parels van de regio’ in het leven? De Board communiceert over ...
Read more
/ News

TropIQ staff co-authors paper in Nature

Nature publishes the paper 'Diversity-oriented synthesis yields novel multistage antimalarial inhibitors' that is co-authored by TropIQ staff. Antimalarial drugs have thus far beenchiefly derived from two sources—natural products and synthetic ...
Read more
/ News

Malaria Journal publishes our newest paper ” An inter-laboratory comparison of the Standard Membrane Feeding Assay”

Here the "gold standard" status for transmission blocking activity of antibodies, the standard membrane feeding assay (SMFA), is verified in two different laboratories. Read the article here. ...
Read more
/ News

TropIQ moves to different location

TropIQ has moved to a brand new laboratory at the Noviotech campus in Nijmegen, The Netherlands ...
Read more
/ News

TropIQ enters consortium

TropIQ has entered a Netherlands-based consortium that teams up with MMV in world-leading malaria translational research ...
Read more
/ News

TropIQ enters partnership

TropIQ enters partnership with MMV (Medicines for Malaria Venture) on generation of a pantothenamide clinical candidate ...
Read more
/ News

Scientific Reports publishes our paper

"A semi-automated luminescence based standard membrane feeding assay identifies novel small molecules that inhibit transmission of malaria parasites by mosquitoes" We describe here for the first time a standard membrane ...
Read more
/ News

TropIQ receives research grant

TropIQ receives a Grand Challenges and Explorations award from the Bill & Melinda Gates Foundation to develop barcoded insect screens for optimization of artificial diets ...
Read more
/ News

TropIQ co-authors Scientific Report publication

TropIQ staff co-authors the study 'A simple and predictive phenotypic High Content Imaging assay for Plasmodium falciparum mature gametocytes to identify malaria transmission blocking compounds' that was published by Scientific Reports today ...
Read more
/ News

TropIQ employees co-author published study

TropIQ employees co-author the study 'A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria' that was published by Science Translational Medicine today ...
Read more
/ News